Navigation Links
Nation's Largest Dialysis Patient Organization Recognizes the Achievements of Patients and Leaders in Kidney Care
Date:9/24/2007

Representative Donna Christensen recognized for her contributions to kidney

care

WASHINGTON, Sept. 24 /PRNewswire-USNewswire/ -- DaVita Patient Citizens (DPC) -- a nationwide patient advocacy group comprised of more than 20,000 dialysis and pre-dialysis patients and family members -- held its annual Gala and Awards program today. Entitled, Celebrating the Empowerment of Kidney Patients, the event brought together dialysis patients and members of the kidney care community to extol the achievements of kidney patients and those within the community who dedicate their lives to improving care.

2007 Gala Award recipients include:

-- Donna M. Christensen, MD. Representative Christensen (D-VI) is the

chair of the Congressional Black Caucus' Health Brain Trust. A

physician, she has been a leader in focusing Congress' attention on

kidney care issues.

-- Jack W. Moncrief, MD. Dr. Moncrief from Austin, TX is credited with

developing Continuous Ambulatory Peritoneal Dialysis -- a method of

dialysis that allows the blood to be cleaned within the abdominal

cavity.

-- American Kidney Fund (AKF). AKF is a leader in providing financial

assistance to chronic kidney disease patients across the nation. In

2006, AKF served more than 63,500 patients, distributing $81.9 million

in grants.

-- Abbott Laboratories. Abbott Laboratories, the makers of Zemplar, are a

key partner of DPC. Their support has allowed DPC to provide kidney

care education to thousands of patients.

-- Ardell Lien. A Minnesotan, Mr. Lien received a heart and kidney

transplant in 2003, and subsequently sailed around the work to raise

awareness about the need for organ donation.

"On behalf of the kidney community, we are honored to recognize the achievements of empowered kidney patients and their advocates," said
'/>"/>

SOURCE DaVita Patient Citizens
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Roche offers HIV drug expertise to poor nations
2. Drug Combinations May Boost Stroke Risk
3. The Link Between Childhood Vaccinations And Diabetes Questioned
4. Research finds new explanations for dyslexia
5. Myth Of Childhood Vaccinations Linked To Increased Hospitalization Busted
6. Breast Cancer Examinations To Be Reviewed In Irish Hospitals
7. Asian Nations Told To Ready Themselves For Pandemic
8. Asian Nations To Take Joint Efforts Against H5N1
9. Media Plays Crucial Role In Flu Vaccinations
10. Drug Combinations Could Be Dangerous
11. Pediatricians Resignations Cause Concern at Sale
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Free Wheelchair Mission Breaks List of Top 60 OC Nonprofits in 2009 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 3New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 61032 1New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 61032 2New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 61032 3Lung Cancer Alliance Staff and Advocates to Ring Closing Bell of New York Stock Exchange 28TM 29 61028 1Lung Cancer Alliance Staff and Advocates to Ring Closing Bell of New York Stock Exchange 28TM 29 61028 2PIA Says Inclusion of Agents in House Healthcare Bill is Positive But Concerns Remain 61024 1PIA Says Inclusion of Agents in House Healthcare Bill is Positive But Concerns Remain 61024 2PIA Says Inclusion of Agents in House Healthcare Bill is Positive But Concerns Remain 61024 3
Other Medicine Technology:MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 10IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 2IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 3IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 4IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 5